高通量血液透析对维持性血液透析患者生存率影响的Meta分析被引量：29

The meta analysis of influence of high flux hemodialysis on survival rate of maintenance hemodialysis patients

下载PDF

导出

摘要目的已知在某些特殊人群,高通量血液透析(high flux hemodialysis,HFHD)能改善维持性血液透析(maintenance hemodialysis,MHD)患者生存率。本研究拟分析总体来说,高通量血液透析是否改善MHD患者生存率。方法检索了PubMed/MEDLINE、EMBASE和Cochrane Library电子数据库的HFHD对MHD患者生存率影响的随机对照试验(randomized controlled trials,RCT)和前瞻性对照试验(prospective controlled trials,PCT),使用优势比进行计算。结果3个RCT和2个PCT共3609名患者被纳入本次研究:5个试验均比较了HFHD与低通量血液透析(low flux hemodialysis,LFHD)对患者生存率的影响。与LFHD组相比,HFHD组患者的生存率没有得到改善(固定效应模型,OR=1.20,Z=1.85,P=0.06,I2=68.1%)。HFHD组在患者平均住院率、心血管死亡率方面与LFHD组无明显差异。结论HFHD不能提高MHD患者生存率,不能降低MHD患者平均住院率和心血管死亡率。 Objective To evaluate the effect of high-flux hemodialysis （HFHD） in the survival rate of maintenance hemodialysis （MHD） patients. Methods randomized controlled trials （RCT） and prospective controlled trials （PCT） studying the effect of HFHD on survival rate of MHD patients were searched in the Pubmed / Medline, EMBASE, and Cochrane Library electronic databases, then the odds ratio was calculated. Results 3609 patients in 3 RCT and 2 PCT were included in this study： the effect of survival rate was compared in the HFHD and LFHD group. Compared with the LFHD group, the survival rate of HFHD group wash not improved （Fixed effect model, OR =1.20, Z=1.85, P=0.06, P=68.1%）. There were no significant difference of average admission rate and cardivascular mortality rate between HFHD group and LFHD group. Conclusions HFHD may not improve the survival rate of MHD patients, and it may not reduce the average admission rate and cardiovascular mortality rate of MHD patients.

作者姜国涛许戎左力

机构地区北京大学第一医院肾脏内科天津市第五中心医院肾脏内科北京大学第一医院肾脏内科(暨肾脏病研究所)

出处《中国血液净化》 2010年第1期12-18,共7页 Chinese Journal of Blood Purification

基金费森尤斯医药用品(上海)有限公司对本研究的资助

关键词高通量血液透析生存率 META分析 high flux hemodialysis Survival rate Meta Analysis

分类号 R459.5 [医药卫生—治疗学]

引文网络
相关文献

参考文献11

1Penne EL, Blankes tijn PJ, Bots ML,et al. Resolving controvers iesregarding hemodiafiltration versus hemodialys is the Dutch Convective Transport Study[J]. Semin Dial,2005,18:47- 51.
2Hornberger JC, Chernew M, Petersen J, et al. A multiwwiate analysis of mortality and hospital admissions with high flux dialysis[J]. J Am Soc Nephrol, 1992, 3:1227 -1237.
3Woods HF, Nandakumar M. Improved outcome for haemodialysis patients treated with high flux membranes[J]. Nephrol Dial Transplant, 2000, 15 Suppl 1:36- 42.
4Santoro A, Mancini E, Bolzani R, et al. The effect of on line high flux hemofiltration versus low flux hemodialysis on mortality in chronic kidney failure: A small randomized controlled trial[J]. Am J kidney dis, 2008, 52:507 -518.
5Chauveau P, Nguyen H, Combe C, et al. Dialyzer membrane permeability and survival in hemodialysis patients[J]. Am J kidney Dis, 2005,45:565- 571.
6Angela K, Carsten A, PopaI M, et al. Effect of Membrane Flux and Dialyzer Biocompatibility on Survival in End Stage Diabetic Nepbropathy[J]. Nephron Clin Pratt, 2008, 109: e154 el60. DOI: 10.1159/000145459.
7Locatelli F, Martin-Malo A, Hanned-ouche T, et al. Journal of the American Society of Nephrology, 2008, Published on December 17, 2008, DOI 10. 1681/ASN. 2008060590.
8Bknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis[J]. New Engl Med, No. December19,2002,347:2010-2019.
9Rabindranath KS, Strippoli GFM, Roderick P, et al. Comparison of hemodialysis, hemofiltration, and Acetate-Free Bio? Itration for ESRD: Systematic Review[J]. Am J Kidney Dis, 2005, 45:437 -447.
10Traut M, Haufe CC, Eismann U, et al. Increased binding of beta 2-microglobulin to blood cells in dialysis patients treated with high-Flux dialyzers compared with low-Flux membranes contributed to reduced beta 2-microglobulin concentrations[J]. Blood Purif, 2007,25:432-440. DOI: 10. 1159/000119069.